Delivery Order SPE2DB22D3004-SPE2DB24FPS54
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,972.30, is for the supply of the pharmaceutical product Tobi Podhaler 28 mg inhalation capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of December 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award, valued at $18,676.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tobi Podhaler 28 mg inhalation capsules and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,186.01 firm fixed-price delivery order is for the supply of 4562300741 Tobi Podhaler 28 mg inhalation capsules. The contract has a completion date of September 26, 2023 and does not include a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a $28,423.85 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tobi Podhaler 28 mg inhalable capsules (56-count unit dose). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is set for completion by September 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location in the same city. The...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,745.92, is for the delivery of 4,562,406,339 units of TOBI PODHALER 28 MG INHALE CAP UD 56S, with an ultimate completion date of October 6, 2023. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,472.14 contract is for the supply of 4,563,348,474 units of the TOBI PODHALER 28 MG INHALE CAP UD 56S pharmaceutical product. The award is under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which provides a comprehensive range of pharmaceutical...
- This is a delivery order contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $41,392.19, is for the delivery of Tobi Podhaler 28 mg inhalation capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 28, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Tobramycin 300 mg/5 ml ampules. The $3,023.34 firm fixed price contract was issued by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,392.13 firm fixed-price delivery order is for the supply of 1.2 gram vials of the drug Tobramycin. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical division....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the delivery of tiotropium 18 mcg cap-inhaler 30s. The $24,678.95 firm fixed price delivery order has an ultimate completion date of April 5, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPS54Delivery Order
The federal contract award SPE2DB22D3004|SPE2DB24FPS54 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $15,245.43 firm fixed price delivery order is for the supply of 4,564,030,051 units of the pharmaceutical product Tobi Podhaler 28 mg Inhalation Capsules. This award is part of a larger $999,999,999.00 indefinite delivery contract held by Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp's parent company is Cencora, Inc., which does business as Amerisourcebergen.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.2k | 3/20/24 |